Patent · US Expired

Pyrrolobenzimidazolones and their use as anti-proliferative agents

US7714010B2 · kind B2 · utility

1Cited by

3References

5Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Darryl McConnel · Wien, AT
Steffen Steurer · Wien, AT
Bernd Krist · Wien, AT
Ulrike Weyer-Czernilofsky · Baden, AT
Maria Impagnatiello · Wien, AT
Matthias Treu · Wien, AT
Iris Kauffmann-Hefner · Biberach an der Riß, DE
Pilar Garin-Chesa · Biberach, DE
Andreas Schnapp · Biberach, DE

Key dates

Filing date	May 17, 2005
Grant date	May 11, 2010
Priority date	—
Expiry date	Dec 15, 2025

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to pyrrolobenzimidazolone compounds of formula (I),wherein A, T and R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation and the use thereof for preparing a pharmaceutical composition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.